ZERO is proud to partner with accredited CME providers to offer prostate cancer continued medical education (CME) hours.
Optimizing Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Wednesday, June 22, 2022 from 4:30 – 5:00pm ET
In this live, virtual event a panel of experts in prostate cancer discuss the practical considerations of oral therapies and common adverse events associated with approved agents for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).
Past CME Webinars
Expanding the Role of Radiopharmaceuticals for Prostate Cancer Management
Join urologists and prostate-cancer experts Dr. Neal Shore and Dr. Michael Gorin to discuss the role of approved and emerging radiopharmaceuticals in the optimal management of prostate cancer. Panelists will compare newer radiotracers with conventional imaging and review recent safety and efficacy data on the integration of molecular imaging into all stages of prostate cancer in this 60 minute CME opportunity. Click here for more information and to view the webinar.
Are you a healthcare provider who would like to have ZERO’s materials in your office? Request your free prostate cancer educational literature here!